Novavax Inc. Stock Rises Wednesday, Still Underperforms Market

Dow Jones
2024-12-12

DJ Novavax Inc. Stock Rises Wednesday, Still Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Novavax Inc. $(NVAX)$ inched 0.57% higher to $8.82 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 1.77% to 20,034.89 and the Dow Jones Industrial Average falling 0.22% to 44,148.56.

Novavax Inc. closed $15.04 short of its 52-week high ($23.86), which the company reached on June 6th.

The stock outperformed some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ fell 1.74% to $146.64, Pfizer Inc. $(PFE)$ fell 1.33% to $25.23, and Merck & Co. Inc. $(MRK)$ fell 1.24% to $99.75.

Trading volume (2.0 M) remained 4.0 million below its 50-day average volume of 6.0 M.

Data source: Dow Jones Market Data, FactSet. Data compiled December 11, 2024.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

December 11, 2024 17:26 ET (22:26 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10